Candela Corporation, et al v. Palomar Medical Technologies, Inc, No. 9:06-cv-00277 (E.D. Tex. June 5, 2008)
From the Opinion
The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.
Before the court is Defendant Palomar Medical Technologies, Inc.’s Letter Brief of May 23, 2008. In it, Palomar states that its first motion for summary judgment will be directed to invalidity and non-infringement of the method claims of the patents-in-suit, based on the argument that the patents are invalid for lack of enablement and that Palomar does not induce infringement of the method claims because there is no evidence that any physician uses the accused devices to treat wrinkles.
Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error